ATE554185T1 - Verfahren und konstrukte zur bewertung von rnai- zielen und effektormolekülen - Google Patents

Verfahren und konstrukte zur bewertung von rnai- zielen und effektormolekülen

Info

Publication number
ATE554185T1
ATE554185T1 AT04714072T AT04714072T ATE554185T1 AT E554185 T1 ATE554185 T1 AT E554185T1 AT 04714072 T AT04714072 T AT 04714072T AT 04714072 T AT04714072 T AT 04714072T AT E554185 T1 ATE554185 T1 AT E554185T1
Authority
AT
Austria
Prior art keywords
methods
constructs
evaluation
effector molecules
rnai
Prior art date
Application number
AT04714072T
Other languages
English (en)
Inventor
Catherine Pachuk
Original Assignee
Alnylam Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alnylam Pharmaceuticals Inc filed Critical Alnylam Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE554185T1 publication Critical patent/ATE554185T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/10—Applications; Uses in screening processes
    • C12N2320/11—Applications; Uses in screening processes for the determination of target sites, i.e. of active nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT04714072T 2003-02-27 2004-02-24 Verfahren und konstrukte zur bewertung von rnai- zielen und effektormolekülen ATE554185T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45107003P 2003-02-27 2003-02-27
PCT/US2004/005065 WO2004076629A2 (en) 2003-02-27 2004-02-24 METHODS AND CONSTRUCTS FOR EVALUATION OF RNAi TARGETS AND EFFECTOR MOLECULES

Publications (1)

Publication Number Publication Date
ATE554185T1 true ATE554185T1 (de) 2012-05-15

Family

ID=32927699

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04714072T ATE554185T1 (de) 2003-02-27 2004-02-24 Verfahren und konstrukte zur bewertung von rnai- zielen und effektormolekülen

Country Status (6)

Country Link
US (1) US20060263764A1 (de)
EP (1) EP1597351B1 (de)
AT (1) ATE554185T1 (de)
AU (1) AU2004214954A1 (de)
CA (1) CA2517235A1 (de)
WO (1) WO2004076629A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1875103A (zh) * 2003-08-29 2006-12-06 宝生物工程株式会社 筛选功能核苷酸分子的方法
WO2005038054A1 (en) * 2003-10-20 2005-04-28 Zicai Liang METHOD OF MEASURING THE EFFICACY OF siRNA MOLECULES
CA2559955C (en) 2004-03-15 2016-02-16 City Of Hope Methods and compositions for the specific inhibition of gene expression by double-stranded rna
US20070265220A1 (en) 2004-03-15 2007-11-15 City Of Hope Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
DE602005024015D1 (de) 2004-08-23 2010-11-18 Alnylam Pharmaceuticals Inc Expressionskonstrukte mit mehreren rna-polymerase-iii-promotoren
DE602005027479D1 (de) 2004-09-24 2011-05-26 Alnylam Pharmaceuticals Inc Targeting von zwischenprodukten zur gegenstrangreplikation von einzelstrangigen viren durch rnai
EP2316942B1 (de) 2004-12-22 2021-04-21 Alnylam Pharmaceuticals, Inc. Zum gen-silencing geeignete konservierte hbv- und hcv-sequenzen
EP1969137B1 (de) * 2005-11-22 2011-10-05 Stichting Dienst Landbouwkundig Onderzoek Multiplex-nukleinsäurenachweis
DK2548438T3 (en) 2006-11-08 2015-10-19 Veritas Bio LLC IN VIVO SUBMITTING DOUBLE-STRENGTH RNA TO A CELL
EP2135080A4 (de) * 2007-03-08 2010-12-01 Switchgear Genomics Funktionelle arrays zur charakterisierung mit hohem durchsatz von regulatorischen elementen in nichttranslatierten bereichen von genen
KR101142209B1 (ko) 2007-09-22 2012-05-04 재단법인서울대학교산학협력재단 섭취 ＲＮＡｉ를 이용한 꼬마선충에서 두 유전자의동시발현 억제방법
CN101173294B (zh) * 2007-10-12 2011-01-26 中山大学 一种基因微链载体及其构建方法和应用
US8815779B2 (en) 2009-09-16 2014-08-26 SwitchGear Genomics, Inc. Transcription biomarkers of biological responses and methods
RS61447B1 (sr) 2011-04-21 2021-03-31 Glaxo Group Ltd Modulacija ekspresije virusa hepatitisa b (hbv)
US10307226B2 (en) 2013-03-14 2019-06-04 National Dentex, Llc Bone foundation guide and method of use
US10278789B2 (en) 2013-03-14 2019-05-07 National Dentex, Llc Bone foundation guide system and method
US10398530B2 (en) 2013-03-14 2019-09-03 National Dentex, Llc Bone foundation guide system and method
EP3265493B1 (de) 2015-03-02 2024-01-10 180 Therapeutics LP Verfahren zur behandlung einer lokalisierten fibrotischen erkrankung unter verwendung eines il-33-antagonisten
EP3364908A1 (de) 2015-10-23 2018-08-29 Daniel R. Llop Knochenfundamentführungssystem und -verfahren
WO2017155823A1 (en) 2016-03-05 2017-09-14 National Dentex, Llc Bone foundation guide system and method
CA3043768A1 (en) 2016-11-29 2018-06-07 PureTech Health LLC Exosomes for delivery of therapeutic agents
KR102234135B1 (ko) * 2019-10-30 2021-03-31 서울대학교산학협력단 GFP 유전자의 발현을 억제하는 dsRNA 및 이의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69434931T2 (de) * 1993-04-02 2007-11-22 Rigel Pharmaceuticals, Inc., South San Francisco Methode zur selektiven inaktivierung der viralen replication
US6013447A (en) 1997-11-21 2000-01-11 Innovir Laboratories, Inc. Random intracellular method for obtaining optimally active nucleic acid molecules
US20020002278A1 (en) * 1999-11-05 2002-01-03 Timothy W. Nilsen Random intracellular method for obtaining optimally active nucleic acid molecules
CA2429814C (en) * 2000-12-01 2014-02-18 Thomas Tuschl Rna interference mediating small rna molecules
CA2369944A1 (en) * 2001-01-31 2002-07-31 Nucleonics Inc. Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
ATE328109T1 (de) * 2001-05-04 2006-06-15 Health Research Inc Test mit hohem durchsatz zur identifizierung von modifikatoren der genexpression

Also Published As

Publication number Publication date
EP1597351B1 (de) 2012-04-18
AU2004214954A1 (en) 2004-09-10
EP1597351A2 (de) 2005-11-23
US20060263764A1 (en) 2006-11-23
WO2004076629A2 (en) 2004-09-10
EP1597351A4 (de) 2006-06-14
CA2517235A1 (en) 2004-09-10
WO2004076629A3 (en) 2005-10-27

Similar Documents

Publication Publication Date Title
ATE554185T1 (de) Verfahren und konstrukte zur bewertung von rnai- zielen und effektormolekülen
WO2003070903A3 (en) RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
ATE540114T1 (de) Verfahren und zusammensetzungen zur schnellen isolierung kleiner rna-moleküle
WO2003070966A3 (en) RNA INTERFERENCE MEDIATED TARGET DISCOVERY AND TARGET VALIDATION USING SHORT INTERFERING NUCLEIC ACID (siNA)
DE60207601D1 (de) Methode für die in vitro synthese von kurzen dobbelsträngigen rnas
GB2397062B (en) RNA interference mediated inhibition of hepatitis c virus (HCV) gene expression using short interfering nucleic acid (siNA)
WO2003072705A3 (en) Rna interference mediated inhibition of cyclin d1 gene expression using short interfering nucleic acid (sina)
WO2006031901A3 (en) SMALL INTERFERING RNAs THAT EFFICIENTLY INHIBIT VIRAL GENE EXPRESSION AND METHODS OF USE THEREOF
WO2008094516A8 (en) Multi-targeting short interfering rnas
ATE411400T1 (de) Verfahren zur verwendung von riboprimern zur strangverdrängungsreplikation von zielsequenzen
DK1606406T4 (da) Short Interfering RNA (siRNA) Analogues
EP2274442A4 (de) Konsensussequenzen von chikungunya-virusproteinen, dafür codierende nukleinsäuremoleküle und zusammensetzungen und verfahren zur verwendung davon
WO2004065600A3 (en) Rna interference by palindromic or modified rna molecules
IN2014CN03921A (de)
WO2003070887A3 (en) RNA INTERFERENCE MEDIATED INHIBITION OF POLYCOMB GROUP PROTEIN EZH2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
EP1597351A3 (de) Verfahren und konstrukte zur bewertung von rnai-zielen und effektormolekülen
EP1522583A3 (de) Durch RNAi bewirkte Hemmung der Expression von dem Placental Growth Factor Gen mittels kleiner interfierender Nukleinsäuren (siNA)
WO2003070888A3 (en) Rna interference mediated inhibition of checkpoint kinase-1 (chk-1) gene expression using short interfering nucleic acid
WO2005045032A3 (en) RNA INTERFERENCE MEDIATED INHIBITION OF EARLY GROWTH RESPONSE GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO2005014811A3 (en) RNA INTERFERENCE MEDIATED INHIBITION OF XIAP GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
ATE420975T1 (de) Methode zur linearen nicht-selektiven amplifikation von nukleinsäuren
EP1710307A3 (de) Durch RNA-Interferenz vermittelte Hemmung der Genexpression unter Verwendung von siNA (short interfering nucleic acid)
van Laar et al. Small RNA next generation sequencing (NGS) of CD138+ plasma cells from multiple myeloma patients and comparison to the 70-gene mRNA-based prognostic risk score
DK1854875T3 (da) Termostabil DNA polymerase af Archaeal-ampullavirus ABV og dets applikationer
Sunil et al. Non-coding genomics.